experts 
Fierce Pharma
APRIL 22, 2024
As a closely watched readout from Alnylam Pharmaceuticals' Amvuttra in the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM) is expected in a few weeks, experts suggested the RNA si | As an all-important readout from Alnylam’s Amvuttra in the rare heart disease ATTR-CM is expected in a few weeks, experts suggested that the RNA (..)
Fierce Pharma
APRIL 9, 2024
For this report, Fierce Pharma spoke with experts to learn about what's at stake, including the need to bring new treatments to patients earlier.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 27, 2023
Although the litigation was launched right after a patent’s issuance, AbbVie may actually have a case here, according to one expert. AbbVie recently filed a patent infring | AbbVie recently filed a patent infringement lawsuit against BeiGene over their blockbuster BTK franchises.
Fierce Pharma
NOVEMBER 29, 2023
The revelation of an FDA investigation< | As industry watchers deliberate the implications from the FDA's investigation into secondary cancer risks from CAR-T medicines, an upcoming expert meeting could offer precious clarity from drug regulators.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.
MedCity News
APRIL 18, 2024
The post Healthcare Docket: Help Wanted — Doctor Expert Witnesses appeared first on MedCity News. Major malpractice verdicts have spiked in recent years.
Fierce Pharma
DECEMBER 11, 2023
ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy aliu Mon, 12/11/2023 - 14:51
Advertiser: ZoomInfo
Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running?
Advertisement
In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials.
Advertiser: ZoomInfo
This report will examine the main investment areas that marketers are prioritizing to enhance their account-based strategies through a focus on: How practitioners are executing and accelerating blended ABM strategies that put self-service buying journeys at the forefront The areas in which AI shows the greatest promise The continued convergence of (..)
Expert insights. Personalized for you.
246 
Let's personalize your content